高胰岛素血症
胰岛素
内科学
内分泌学
新陈代谢
碳水化合物代谢
胰岛素振荡
高胰岛素血症
医学
生物
胰岛素抵抗
作者
Dale S. Edgerton,Mary Courtney Moore,Justin M. Gregory,Guillaume Kraft,Alan D. Cherrington
出处
期刊:American Journal of Physiology-endocrinology and Metabolism
[American Physiological Society]
日期:2021-04-05
卷期号:320 (5): E891-E897
被引量:30
标识
DOI:10.1152/ajpendo.00628.2020
摘要
Pancreatic insulin secretion produces an insulin gradient at the liver compared with the rest of the body (approximately 3:1). This physiological distribution is lost when insulin is injected subcutaneously, causing impaired regulation of hepatic glucose production and whole body glucose uptake, as well as arterial hyperinsulinemia. Thus, the hepatoportal insulin gradient is essential to the normal control of glucose metabolism during both fasting and feeding. Insulin can regulate hepatic glucose production and uptake through multiple mechanisms, but its direct effects on the liver are dominant under physiological conditions. Given the complications associated with iatrogenic hyperinsulinemia in patients treated with insulin, insulin designed to preferentially target the liver may have therapeutic advantages.
科研通智能强力驱动
Strongly Powered by AbleSci AI